Precision Medicine News and Updates | Precision Medicine Online
WEBThe plan, announced in January, would reclassify many Class III in vitro diagnostic devices as Class II, impacting companion diagnostic and infectious disease tests. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Oncology News - Precision Medicine Online
WEBGuardant Health Liquid Biopsy CDx Gets Japanese Regulatory Approval for Janssen Lung Cancer Drug. Aug 30, 2024. Hackensack Meridien Health Launches Cancer Risk, Early Detection Program; Eyes Multi-Cancer Testing. Aug 29, 2024. MOMA Therapeutics Advances Cancer Drugs Interrogating Cell Molecular Machinery Into Clinic. Aug 29, 2024.
Amgen's Lumakras Combo Scores High Response Rate in First …
WEB2 days ago · NEW YORK – The first data from a trial of Amgen's KRAS inhibitor Lumakras (sotorasib) combined with its anti-EGFR monoclonal antibody Vectibix (panitumumab) and chemo in first-line KRAS G12C-mutant metastatic colorectal cancer showed that more than three-fourths of patients in a cohort of 40 saw their tumors shrink.
Disease Research & Diagnostics News | Precision Medicine Online
WEBNews and analysis on disease research and diagnostics from Precision Medicine Online.
Breaking News - Precision Medicine Online
WEBSep 13, 2024 · IN8bio to Lay off Nearly Half of Workforce, Narrow Pipeline Focus on AML Cell Therapy. The firm is dropping two glioblastoma programs and cutting 49 percent of its staff to advance its gamma delta T-cell therapy INB …
Autoimmune Disease Research News - Precision Medicine Online
WEBJun 20, 2024 · JW Therapeutics, 2seventy Bio Partner to Develop Cell Therapy for Autoimmune Diseases in China. News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more from Precision Medicine Online.
Brenus Pharma Raises $25M in Series A Round to Advance Cancer …
WEB1 day ago · Save for later. NEW YORK – Brenus Pharma on Wednesday announced that it has raised $25 million in a Series A financing round, which it plans to put toward advancing its allogeneic cancer vaccines. Investment fund Angelor led the round and brought together a number of other investors from the Auvergne-Rhône-Alpes (AURA) region, including UI ...
AbbVie's Telisotuzumab Vedotin Effective in NSCLC Patients With …
WEB6 days ago · NEW YORK – AbbVie's MET-targeting antibody-drug conjugate telisotuzumab vedotin led to durable responses in patients with c-MET-overexpressing EGFR-wildtype non-small cell lung cancer in a Phase II study. The results from the LUMINOSITY trial, presented at the International Association for the ...
Cardiovascular Disease Research News - Precision Medicine Online
WEBJul 3, 2024 · News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more from Precision Medicine Online.
NanoVation Therapeutics, Novo Nordisk to Develop Base-Editing …
WEB2 days ago · NEW YORK – Novo Nordisk and NanoVation Therapeutics on Wednesday announced a multiyear partnership to develop multiple genetic medicines for cardiometabolic and rare diseases. As part of the deal, Vancouver-based NanoVation will receive an unspecified amount of research funding from Novo Nordisk ...